Literature DB >> 30771035

Oxidative stress and epigenetic mortality risk score: associations with all-cause mortality among elderly people.

Xu Gao1,2,3, Xīn Gào1,2,4, Yan Zhang1, Bernd Holleczek5, Ben Schöttker1,4, Hermann Brenner6,7,8,9.   

Abstract

Oxidative stress (OS) has been found to be related to accelerated aging and many aging-related health outcomes. Recently, an epigenetic "mortality risk score" (MS) based on whole blood DNA methylation at 10 mortality-related CpG sites has been demonstrated to be associated with all-cause mortality. This study aimed to address the association between OS and MS, and to assess and compare their performance in the prediction of all-cause mortality. For 1448 participants aged 50-75 of the German ESTHER cohort study, the MS was derived from the DNA methylation profiles measured by Illumina HumanMethylation450K Beadchip and the levels of two urinary OS markers, 8-isoprostane (8-iso) and oxidized guanine/guanosine [including 8-hydroxy-2'-deoxyguanosine (8-oxo)], were measured by ELISA kits. Associations between OS markers and the MS were evaluated by linear and ordinal logistic regression models, and their associations with all-cause mortality were examined by Cox regression models. Both OS markers were associated with the MS at baseline. The 8-iso levels and MS, but not 8-oxo levels, were associated with all-cause mortality during a median follow-up of 15.1 years. Fully-adjusted hazard ratios (95% CI) were 1.56 (1.13-2.16) for the 4th quartile of 8-iso levels compared with the 1st, 1.71 (1.27-2.29) and 2.92 (2.03-4.18) for the moderate and high MS defined by 2-5 and > 5 CpG sites with aberrant methylation compared with a MS of 0-1, respectively. After controlling for 8-iso levels, the hazard ratios of MS remained essentially unchanged while the association of 8-iso levels with mortality was attenuated. This study demonstrates that OS is highly associated with the epigenetic MS, and the latter at the same time has a higher predictive value for all-cause mortality.

Entities:  

Keywords:  Aging; All-cause mortality; DNA methylation; Epigenetic epidemiology; Mortality risk score; Oxidative stress

Mesh:

Year:  2019        PMID: 30771035     DOI: 10.1007/s10654-019-00493-7

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  9 in total

1.  Associations of dietary and lifestyle oxidative balance scores with mortality risk among older women: the Iowa Women's Health Study.

Authors:  Ziling Mao; Anna E Prizment; DeAnn Lazovich; Roberd M Bostick
Journal:  Eur J Nutr       Date:  2021-04-21       Impact factor: 5.614

2.  Potential of Inflammatory Protein Signatures for Enhanced Selection of People for Lung Cancer Screening.

Authors:  Megha Bhardwaj; Ben Schöttker; Bernd Holleczek; Axel Benner; Petra Schrotz-King; Hermann Brenner
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

3.  DNA Hypomethylation of the MPO Gene in Peripheral Blood Leukocytes Is Associated with Cerebral Stroke in the Acute Phase.

Authors:  Olga Bushueva; Ekaterina Barysheva; Anton Markov; Andrey Belykh; Iuliia Koroleva; Egor Churkin; Alexey Polonikov; Vladimir Ivanov; Maria Nazarenko
Journal:  J Mol Neurosci       Date:  2021-04-17       Impact factor: 3.444

4.  Blood-derived DNA methylation predictors of mortality discriminate tumor and healthy tissue in multiple organs.

Authors:  Yan Zhang; Melanie Bewerunge-Hudler; Matthias Schick; Barbara Burwinkel; Esther Herpel; Michael Hoffmeister; Hermann Brenner
Journal:  Mol Oncol       Date:  2020-06-22       Impact factor: 6.603

5.  Objectives, design and main findings until 2020 from the Rotterdam Study.

Authors:  M Arfan Ikram; Guy Brusselle; Mohsen Ghanbari; André Goedegebure; M Kamran Ikram; Maryam Kavousi; Brenda C T Kieboom; Caroline C W Klaver; Robert J de Knegt; Annemarie I Luik; Tamar E C Nijsten; Robin P Peeters; Frank J A van Rooij; Bruno H Stricker; André G Uitterlinden; Meike W Vernooij; Trudy Voortman
Journal:  Eur J Epidemiol       Date:  2020-05-04       Impact factor: 8.082

6.  Retinal photograph-based deep learning predicts biological age, and stratifies morbidity and mortality risk.

Authors:  Simon Nusinovici; Tyler Hyungtaek Rim; Marco Yu; Geunyoung Lee; Yih-Chung Tham; Ning Cheung; Crystal Chun Yuen Chong; Zhi Da Soh; Sahil Thakur; Chan Joo Lee; Charumathi Sabanayagam; Byoung Kwon Lee; Sungha Park; Sung Soo Kim; Hyeon Chang Kim; Tien-Yin Wong; Ching-Yu Cheng
Journal:  Age Ageing       Date:  2022-04-01       Impact factor: 10.668

7.  Vascular endothelial growth factor (VEGF) polymorphism rs3025039 and atherosclerosis among older with hypertension.

Authors:  Yuji Shimizu; Kazuhiko Arima; Yuko Noguchi; Hirotomo Yamanashi; Shin-Ya Kawashiri; Kenichi Nobusue; Fumiaki Nonaka; Kiyoshi Aoyagi; Yasuhiro Nagata; Takahiro Maeda
Journal:  Sci Rep       Date:  2022-04-01       Impact factor: 4.379

8.  1H NMR Urinary Metabolomic Analysis in Older Adults after Hip Fracture Surgery May Provide Valuable Information for Patient Profiling-A Preliminary Investigation.

Authors:  Wafa Douzi; Delphine Bon; Sara Suikkanen; Paula Soukkio; Nadège Boildieu; Arja Nenonen; Markku Hupli; Katriina Kukkonen-Harjula; Benoit Dugué
Journal:  Metabolites       Date:  2022-08-12

9.  DNAm-based signatures of accelerated aging and mortality in blood are associated with low renal function.

Authors:  Nora Franceschini; Melanie Waldenberger; Pamela R Matías-García; Cavin K Ward-Caviness; Laura M Raffield; Xu Gao; Yan Zhang; Rory Wilson; Xīn Gào; Jana Nano; Andrew Bostom; Elena Colicino; Adolfo Correa; Brent Coull; Charles Eaton; Lifang Hou; Allan C Just; Sonja Kunze; Leslie Lange; Ethan Lange; Xihong Lin; Simin Liu; Jamaji C Nwanaji-Enwerem; Alex Reiner; Jincheng Shen; Ben Schöttker; Pantel Vokonas; Yinan Zheng; Bessie Young; Joel Schwartz; Steve Horvath; Ake Lu; Eric A Whitsel; Wolfgang Koenig; Jerzy Adamski; Juliane Winkelmann; Hermann Brenner; Andrea A Baccarelli; Christian Gieger; Annette Peters
Journal:  Clin Epigenetics       Date:  2021-06-02       Impact factor: 7.259

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.